Prolonged survival using anti-CD20 combined chemotherapy in primary prostatic intravascular large B-cell lymphoma

Pathology and Oncology Research

Volumn 14, Issue 3, 2008, Pages 281-284

  Csomor, Judit ^a   Kaszás, Ilona ^b   Kollár, Balázs ^c   Pajor, László ^d   Egyházi, Zsolt ^c   Fekete, Sándor ^e   Egyed, Miklós ^c   Timár, Botond ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b St Margit Hospital   (Hungary)

^c Kaposi Mor Teaching Hospital   (Hungary)

^d UNIVERSITY OF PÉCS   (Hungary)

^e Szent Laszlo Hospital   (Hungary)

Author keywords

DLBCL; Intravascular large B cell lymphoma; Prostate; Rituximab

Indexed keywords

CD20 ANTIBODY; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

AGED; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CASE REPORT; CELL INFILTRATION; CLINICAL FEATURE; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAVASCULAR LARGE B CELL LYMPHOMA; LYMPH NODE BIOPSY; MALE; PROSTATECTOMY; URINARY TRACT OBSTRUCTION;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; EPIRUBICIN; ETOPOSIDE; FATAL OUTCOME; HUMANS; IFOSFAMIDE; LYMPHOMA, B-CELL; MALE; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL;

EID: 58549105318     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-008-9051-y     Document Type: Article

References (13)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds) (2001) World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC, Lyon
2. AJ Ferreri E Campo JF Seymour R Willemze F Ilariucci A Ambrosetti 2004 Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant' Br J Haematol 127 2 173 183
3. DG Bostwick KA Iczkowski MB Amin G Discigil B Osborne 1998 Malignant lymphoma involving the prostate: report of 62 cases Cancer 83 4 732 738
4. PG Chu Q Huang LM Weiss 2005 Incidental and concurrent malignant lymphomas discovered at the time of prostatectomy and prostate biopsy: a study of 29 cases Am J Surg Pathol 29 5 693 699
5. XR Yin H Liu HQ Chen 2005 Intravascular lymphomatosis of the prostate gland Zhonghua Bing Li Xue Za Zhi 34 3 189 190
6. J Alfaro A Espinoza M Manŕiquez L Moyano N González M Larrondo G Figueroa 2004 Intravascular lymphoma treated with anti CD20 monoclonal antibodies. Report of one case Rev Med Chil 132 11 1403 1406
7. G Quintini V Barbera V Franco AM Florena V Spadola G Mariani 2003 Uncommon presentations of non-Hodgkin's lymphoma: case 1. Intravascular large B-cell lymphoma: diagnosis on prostate biopsy J Clin Oncol 21 3 564 565
8. CS Chim F Loong 2002 Intravascular lymphomatosis of the prostate gland Br J Haematol 119 1 2
9. M Ponzoni G Arrigoni VE Gould B Del Curto M Maggioni A Scapinello 2000 Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis Hum Pathol 31 2 220 226
10. Y Kishi M Kami E Kusumi T Mineyama D Kato T Hamaki 2004 Prostatic acid phosphatase: a possible diagnostic marker of intravascular large B-cell lymphoma Haematologica 89 5 ECR13
11. J Odawara N Asada T Aoki M Yamakura M Takeuchi T Ohuchi 2007 18F-Fluorodeoxyglucose positron emission tomography for evaluation of intravascular large B-cell lymphoma Br J Haematol 136 5 684
12. M Bouzani T Karmiris D Rontogianni S Delimpassi J Apostolidis M Mpakiri 2006 Disseminated intravascular B-cell lymphoma: clinicopathological features and outcome of three cases treated with anthracycline-based immunochemotherapy Oncologist 11 8 923 928
13. T Ohno T Sakamoto C Mizumoto T Miyoshi M Ueda T Takeoka 2006 Leukemic and meningeal relapse of CD5+ intravascular large B-cell lymphoma with down-modulation of CD20 after rituximab therapy Int J Hematol 84 1 74 78